|
1
|
Orkin SH and Zon LI: Hematopoiesis: An
evolving paradigm for stem cell biology. Cell. 132:631–644. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Teitell MA and Mikkola HK: Transcriptional
activators, repressors, and epigenetic modifiers controlling
hematopoietic stem cell development. Pediatr Res. 59:33R–39R. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wickrema A and Crispino JD: Erythroid and
megakaryocytic transformation. Oncogene. 26:6803–6815. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tijssen MR, Cvejic A, Joshi A, Hannah RL,
Ferreira R, Forrai A, Bellissimo DC, Oram SH, Smethurst PA, Wilson
NK, et al: Genome-wide analysis of simultaneous GATA1/2, RUNX1,
FLI1, and SCL binding in megakaryocytes identifies hematopoietic
regulators. Dev Cell. 20:597–609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Subramanian S, Thoms JAI, Huang Y,
Cornejo-Páramo P, Koch FC, Jacquelin S, Shen S, Song E, Joshi S,
Brownlee C, et al: Genome-wide transcription factor binding maps
reveal cell-specific changes in the regulatory architecture of
human HSPC. Blood. 142:1448–1462. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beck D, Thoms JA, Perera D, Schütte J,
Unnikrishnan A, Knezevic K, Kinston SJ, Wilson NK, O'Brien TA,
Göttgens B, et al: Genome-wide analysis of transcriptional
regulators in human HSPCs reveals a densely interconnected network
of coding and noncoding genes. Blood. 122:e12–e22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Diffner E, Beck D, Gudgin E, Thoms JA,
Knezevic K, Pridans C, Foster S, Goode D, Lim WK, Boelen L, et al:
Activity of a heptad of transcription factors is associated with
stem cell programs and clinical outcome in acute myeloid leukemia.
Blood. 121:2289–2300. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ben-David Y, Giddens EB and Bernstein A:
Identification and mapping of a common proviral integration site
Fli-1 in erythroleukemia cells induced by friend murine leukemia
virus. Proc Natl Acad Sci USA. 87:1332–1336. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ben-David Y, Giddens EB, Letwin K and
Bernstein A: Erythroleukemia induction by Friend murine leukemia
virus: Insertional activation of a new member of the ets gene
family, Fli-1, closely linked to c-ets-1. Genes Dev. 5:908–918.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pereira R, Quang CT, Lesault I, Dolznig H,
Beug H and Ghysdael J: FLI-1 inhibits differentiation and induces
proliferation of primary erythroblasts. Oncogene. 18:1597–1608.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tamir A, Howard J, Higgins RR, Li YJ,
Berger L, Zacksenhaus E, Reis M and Ben-David Y: Fli-1, an
Ets-related transcription factor, regulates erythropoietin-induced
erythroid proliferation and differentiation: Evidence for direct
transcriptional repression of the Rb gene during differentiation.
Mol Cell Biol. 19:4452–4464. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Athanasiou M, Mavrothalassitis G,
Sun-Hoffman L and Blair DG: FLI-1 is a suppressor of erythroid
differentiation in human hematopoietic cells. Leukemia. 14:439–445.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Starck J, Weiss-Gayet M, Gonnet C, Guyot
B, Vicat JM and Morlé F: Inducible Fli-1 gene deletion in adult
mice modifies several myeloid lineage commitment decisions and
accelerates proliferation arrest and terminal erythrocytic
differentiation. Blood. 116:4795–4805. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu T, Yao Y, Zhang G, Wang Y, Deng B,
Song J, Li X, Han F, Xiao X, Yang J, et al: A screen for Fli-1
transcriptional modulators identifies PKC agonists that induce
erythroid to megakaryocytic differentiation and suppress
leukemogenesis. Oncotarget. 8:16728–16743. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu F, Walmsley M, Rodaway A and Patient
R: Fli1 acts at the top of the transcriptional network driving
blood and endothelial development. Curr Biol. 18:1234–1240. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ben-David Y, Gajendran B, Sample KM and
Zacksenhaus E: Current insights into the role of Fli-1 in
hematopoiesis and malignant transformation. Cell Mol Life Sci.
79:1632022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Love PE, Warzecha C and Li L: Ldb1
complexes: The new master regulators of erythroid gene
transcription. Trends Genet. 30:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li L, Lee JY, Gross J, Song SH, Dean A and
Love PE: A requirement for Lim domain binding protein 1 in
erythropoiesis. J Exp Med. 207:2543–2550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee J, Krivega I, Dale RK and Dean A: The
LDB1 complex Co-opts CTCF for erythroid lineage-specific long-range
enhancer interactions. Cell Rep. 19:2490–2502. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Soler E, Andrieu-Soler C, de Boer E, Bryne
JC, Thongjuea S, Stadhouders R, Palstra RJ, Stevens M, Kockx C, van
Ijcken W, et al: The genome-wide dynamics of the binding of Ldb1
complexes during erythroid differentiation. Genes Dev. 24:277–289.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krivega I, Dale RK and Dean A: Role of
LDB1 in the transition from chromatin looping to transcription
activation. Genes Dev. 28:1278–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deng W, Lee J, Wang H, Miller J, Reik A,
Gregory PD, Dean A and Blobel GA: Controlling long-range genomic
interactions at a native locus by targeted tethering of a looping
factor. Cell. 149:1233–1244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stadhouders R, Cico A, Stephen T,
Thongjuea S, Kolovos P, Baymaz HI, Yu X, Demmers J, Bezstarosti K,
Maas A, et al: Control of developmentally primed erythroid genes by
combinatorial co-repressor actions. Nat Commun. 6:88932015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Giraud G, Kolovos P, Boltsis I, van
Staalduinen J, Guyot B, Weiss-Gayet M, IJcken WV, Morlé F and
Grosveld F: Interplay between FLI-1 and the LDB1 complex in murine
erythroleukemia cells and during megakaryopoiesis. iScience.
24:1022102021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Eisbacher M, Holmes ML, Newton A, Hogg PJ,
Khachigian LM, Crossley M and Chong BH: Protein-protein interaction
between Fli-1 and GATA-1 mediates synergistic expression of
megakaryocyte-specific genes through cooperative DNA binding. Mol
Cell Biol. 23:3427–3441. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li YJ, Zhao X, Vecchiarelli-Federico LM,
Li Y, Datti A, Cheng Y and Ben-David Y: Drug-mediated inhibition of
Fli-1 for the treatment of leukemia. Blood Cancer J. 2:e542012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang C, Song J, Liu W, Yao Y, Kapranov P,
Sample KM, Gajendran B, Zacksenhaus E, Hao X and Ben-David Y: FLI1
promotes protein translation via the transcriptional regulation of
MKNK1 expression. Int J Oncol. 56:430–438. 2020.PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang C, Sample KM, Gajendran B, Kapranov
P, Liu W, Hu A, Zacksenhaus E, Li Y, Hao X and Ben-David Y: FLI1
induces megakaryopoiesis gene expression through WAS/WIP-dependent
and independent mechanisms; Implications for wiskott-aldrich
syndrome. Front Immunol. 12:6078362021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen C, Chen H, Zhang Y, Thomas HR, Frank
MH, He Y and Xia R: TBtools: An integrative toolkit developed for
interactive analyses of big biological data. Mol Plant.
13:1194–1202. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song J, Yuan C, Yang J, Liu T, Yao Y, Xiao
X, Gajendran B, Xu D, Li YJ, Wang C, et al: Novel flavagline-like
compounds with potent Fli-1 inhibitory activity suppress diverse
types of leukemia. FEBS J. 285:4631–4645. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Barbeau B, Barat C, Bergeron D and Rassart
E: The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS
dual element in the Fli-1 exon 1. Oncogene. 18:5535–5545. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
An X and Chen L: Flow cytometry (FCM)
analysis and fluorescence-activated cell sorting (FACS) of
erythroid cells. Methods Mol Biol. 1698:153–174. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakahata T and Okumura N: Cell surface
antigen expression in human erythroid progenitors: Erythroid and
megakaryocytic markers. Leuk Lymphoma. 13:401–409. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
ENCODE Project Consortium, . An integrated
encyclopedia of DNA elements in the human genome. Nature.
489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang P, Basu P, Redmond LC, Morris PE,
Rupon JW, Ginder GD and Lloyd JA: A functional screen for
Krüppel-like factors that regulate the human gamma-globin gene
through the CACCC promoter element. Blood Cells Mol Dis.
35:227–235. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Starck J, Cohet N, Gonnet C, Sarrazin S,
Doubeikovskaia Z, Doubeikovski A, Verger A, Duterque-Coquillaud M
and Morle F: Functional cross-antagonism between transcription
factors FLI-1 and EKLF. Mol Cell Biol. 23:1390–1402. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Neuwirtova R, Fuchs O, Holicka M, Vostry
M, Kostecka A, Hajkova H, Jonasova A, Cermak J, Cmejla R,
Pospisilova D, et al: Transcription factors Fli1 and EKLF in the
differentiation of megakaryocytic and erythroid progenitor in
5q-syndrome and in Diamond-Blackfan anemia. Ann Hematol. 92:11–18.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Merika M and Orkin SH: Functional synergy
and physical interactions of the erythroid transcription factor
GATA-1 with the Krüppel family proteins Sp1 and EKLF. Mol Cell
Biol. 15:2437–2447. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yamaoka A, Suzuki M, Katayama S, Orihara
D, Engel JD and Yamamoto M: EVI1 and GATA2 misexpression induced by
inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and
leukemogenesis. Blood Adv. 4:1722–1736. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Johnson KD, Conn DJ, Shishkova E,
Katsumura KR, Liu P, Shen S, Ranheim EA, Kraus SG, Wang W, Calvo
KR, et al: Constructing and deconstructing GATA2-regulated cell
fate programs to establish developmental trajectories. J Exp Med.
217:e201915262020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yi G, Mandoli A, Jussen L, Tijchon E, van
Bergen MGJM, Cordonnier G, Hansen M, Kim B, Nguyen LN, Jansen PWTC,
et al: CBFβ-MYH11 interferes with megakaryocyte differentiation via
modulating a gene program that includes GATA2 and KLF1. Blood
Cancer J. 9:332019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ikonomi P, Rivera CE, Riordan M,
Washington G, Schechter AN and Noguchi CT: Overexpression of GATA-2
inhibits erythroid and promotes megakaryocyte differentiation. Exp
Hematol. 28:1423–1431. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Y, Ke Q, Shao Y, Zhu G, Li Y, Geng N,
Jin F and Li F: GATA1 induces epithelial-mesenchymal transition in
breast cancer cells through PAK5 oncogenic signaling. Oncotarget.
6:4345–4356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu J, Liu M, Liu H and Zhou L: GATA1
promotes colorectal cancer cell proliferation, migration and
invasion via activating AKT signaling pathway. Mol Cell Biochem.
457:191–199. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Carmichael CL, Metcalf D, Henley KJ, Kruse
EA, Di Rago L, Mifsud S, Alexander WS and Kile BT: Hematopoietic
overexpression of the transcription factor Erg induces lymphoid and
erythro-megakaryocytic leukemia. Proc Natl Acad Sci USA.
109:15437–15442. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mukhopadhyay M, Teufel A, Yamashita T,
Agulnick AD, Chen L, Downs KM, Schindler A, Grinberg A, Huang SP,
Dorward D and Westphal H: Functional ablation of the mouse Ldb1
gene results in severe patterning defects during gastrulation.
Development. 130:495–505. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Song SH, Kim A, Ragoczy T, Bender MA,
Groudine M and Dean A: Multiple functions of Ldb1 required for
beta-globin activation during erythroid differentiation. Blood.
116:2356–2364. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Visvader JE, Mao X, Fujiwara Y, Hahm K and
Orkin SH: The LIM-domain binding protein Ldb1 and its partner LMO2
act as negative regulators of erythroid differentiation. Proc Natl
Acad Sci USA. 94:13707–13712. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu T, Xia L, Yao Y, Yan C, Fan Y,
Gajendran B, Yang J, Li YJ, Chen J, Filmus J, et al: Identification
of diterpenoid compounds that interfere with Fli-1 DNA binding to
suppress leukemogenesis. Cell Death Dis. 10:1172019. View Article : Google Scholar : PubMed/NCBI
|
